doi: 10.3389/fmed.2025.1526090 Received 11 November 2024 Accepted 30 January 2025 Published 14 February 2025 Volume 12 - 2025 Edited by Anil Kumar Pasupulati, University of Hyderabad, India Reviewed by Nasar Alwahaibi, Sultan Qaboos University, Oman Pedro Paulo Scariot, Sao Francisco University, Brazil Updates Copyright 2025 Boima, Agyekum, Ganatra, Agyekum, Kwakyi, Inusah, Ametefe and Adu
Salts of proteins and peptides are well known in the art
Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM)
A molecule that is not what its label claims is not simply ineffective, it is a genuine safety concern, because you cannot know what you are actually putting into your body
Healthy adults are exploring its potential for cognitive enhancement and longevity